F-box proteins: Keeping the epithelial-to-mesenchymal transition (EMT) in check

Seminars in Cancer Biology

Volumn 36, Issue , 2016, Pages 71-79

  Díaz, Víctor M ^a,b,c   de Herreros, Antonio García ^a,b,c  

^a HOSPITAL DEL MAR   (Spain)

^b UNIVERSITAT POMPEU FABRA   (Spain)

^c Barcelona Biomedical Research Park   (Spain)

Author keywords

Cancer; EMT; F box; Proteasome; Snail; Twist; Ubiquitination; Zeb

Indexed keywords

BETA TRANSDUCIN REPEAT CONTAINING PROTEIN; F BOX PROTEIN; FBXL14 PROTEIN; FBXL5 PROTEIN; FBXO11 PROTEIN; FBXO45 PROTEIN; FBXW7 PROTEIN; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR SNAIL1; TRANSCRIPTION FACTOR SNAIL2; TRANSCRIPTION FACTOR TWIST; TRANSCRIPTION FACTOR ZEB1; TRANSCRIPTION FACTOR ZEB2; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; CULLIN; CULLIN 1; MULTIPROTEIN COMPLEX; PROTEIN BINDING; PROTEIN SERINE THREONINE KINASE; SIGNAL PEPTIDE; TRIB1 PROTEIN, HUMAN; TWIST RELATED PROTEIN 1; UBIQUITIN PROTEIN LIGASE; ZEB1 PROTEIN, HUMAN;

CANCER GROWTH; CARCINOGENESIS; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; REVIEW; TUMOR INVASION; UBIQUITINATION; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEOPLASMS; PROTEIN DOMAIN;

ANIMALS; CULLIN PROTEINS; EPITHELIAL-MESENCHYMAL TRANSITION; F-BOX PROTEINS; GENE EXPRESSION REGULATION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MULTIPROTEIN COMPLEXES; NEOPLASMS; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN-SERINE-THREONINE KINASES; SNAIL FAMILY TRANSCRIPTION FACTORS; TWIST-RELATED PROTEIN 1; UBIQUITIN-PROTEIN LIGASES; ZINC FINGER E-BOX-BINDING HOMEOBOX 1;

EID: 84958184805     PISSN: 1044579X     EISSN: 10963650     Source Type: Journal    
DOI: 10.1016/j.semcancer.2015.10.003     Document Type: Review

References (166)

1. Ordureau A., Munch C., Harper J.W. Quantifying ubiquitin signaling. Mol. Cell 2015, 58:660-676.
2. Kim W., Bennett E.J., Huttlin E.L., Guo A., Li J., Possemato A., et al. Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol. Cell 2011, 44:325-340.
3. Weissman A.M., Shabek N., Ciechanover A. The predator becomes the prey: regulating the ubiquitin system by ubiquitylation and degradation. Nat. Rev. Mol. Cell Biol. 2011, 12:605-620.
4. Lipkowitz S., Weissman A.M. RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis. Nat. Rev. Cancer 2011, 11:629-643.
5. Komander D., Clague M.J., Urbe S. Breaking the chains: structure and function of the deubiquitinases. Nat. Rev. Mol. Cell Biol. 2009, 10:550-563.
6. Skaar J.R., Pagan J.K., Pagano M. Mechanisms and function of substrate recruitment by F-box proteins. Nat. Rev. Mol. Cell Biol. 2013, 14:369-381.
7. Cenciarelli C., Chiaur D.S., Guardavaccaro D., Parks W., Vidal M., Pagano M. Identification of a family of human F-box proteins. Curr. Biol. 1999, 9:1177-1179.
8. Cardozo T., Pagano M., The S.C.F. ubiquitin ligase: insights into a molecular machine. Nat. Rev. Mol. Cell Biol. 2004, 5:739-751.
9. Richardson K.S., Zundel W. The emerging role of the COP9 signalosome in cancer. Mol. Cancer Res. 2005, 3:645-653.
10. Wu J.T., Lin H.C., Hu Y.C., Chien C.T. Neddylation and deneddylation regulate Cul1 and Cul3 protein accumulation. Nat. Cell Biol. 2005, 7:1014-1020.
11. Bornstein G., Ganoth D., Hershko A. Regulation of neddylation and deneddylation of cullin1 in SCFSkp2 ubiquitin ligase by F-box protein substrate. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:11515-11520.
12. Wang Z., Liu P., Inuzuka H., Wei W. Roles of F-box proteins in cancer. Nat. Rev. Cancer 2014, 14:233-247.
13. Petroski M.D., Deshaies R.J. Function and regulation of cullin-RING ubiquitin ligases. Nat. Rev. Mol. Cell Biol. 2005, 6:9-20.
14. Jin J., Cardozo T., Lovering R.C., Elledge S.J., Pagano M., Harper J.W. Systematic analysis and nomenclature of mammalian F-box proteins. Genes Dev. 2004, 18:2573-2580.
15. Greenburg G., Hay E.D. Epithelia suspended in collagen gels can lose polarity and express characteristics of migrating mesenchymal cells. J. Cell Biol. 1982, 95:333-339.
16. Thiery J.P., Acloque H., Huang R.Y., Nieto M.A. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139:871-890.
17. Yang J., Weinberg R.A. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev. Cell 2008, 14:818-829.
18. Lim J., Thiery J.P. Epithelial-mesenchymal transitions: insights from development. Development 2012, 139:3471-3486.
19. Thiery J.P. Epithelial-mesenchymal transitions in development and pathologies. Curr. Opin. Cell Biol. 2003, 15:740-746.
20. Lamouille S., Xu J., Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat. Rev. Mol. Cell Biol. 2014, 15:178-196.
21. Peinado H., Olmeda D., Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?. Nat. Rev. Cancer 2007, 7:415-428.
22. Taddei M.L., Giannoni E., Comito G., Chiarugi P. Microenvironment and tumor cell plasticity: an easy way out. Cancer Lett. 2013, 341:80-96.
23. Rhim A.D., Mirek E.T., Aiello N.M., Maitra A., Bailey J.M., McAllister F., et al. EMT and dissemination precede pancreatic tumor formation. Cell 2012, 148:349-361.
24. Friedl P., Alexander S. Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 2011, 147:992-1009.
25. Hanahan D., Coussens L.M. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 2012, 21:309-322.
26. Baulida J., Garcia de Herreros A. Snail1-driven plasticity of epithelial and mesenchymal cells sustains cancer malignancy. Biochim. Biophys. Acta 2015, 1856:55-61.
27. Stanisavljevic J., Loubat-Casanovas J., Herrera M., Luque T., Pena R., Lluch A., et al. Snail1-expressing fibroblasts in the tumor microenvironment display mechanical properties that support metastasis. Cancer Res. 2015, 75:284-295.
28. Wu W.S., Heinrichs S., Xu D., Garrison S.P., Zambetti G.P., Adams J.M., et al. Slug antagonizes p53-mediated apoptosis of hematopoietic progenitors by repressing puma. Cell 2005, 123:641-653.
29. Escriva M., Peiro S., Herranz N., Villagrasa P., Dave N., Montserrat-Sentis B., et al. Repression of PTEN phosphatase by Snail1 transcriptional factor during gamma radiation-induced apoptosis. Mol. Cell. Biol. 2008, 28:1528-1540.
30. Inoue A., Seidel M.G., Wu W., Kamizono S., Ferrando A.A., Bronson R.T., et al. Slug, a highly conserved zinc finger transcriptional repressor, protects hematopoietic progenitor cells from radiation-induced apoptosis in vivo. Cancer Cell 2002, 2:279-288.
31. Batlle E., Sancho E., Franci C., Dominguez D., Monfar M., Baulida J., et al. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat. Cell Biol. 2000, 2:84-89.
32. Cano A., Perez-Moreno M.A., Rodrigo I., Locascio A., Blanco M.J., del Barrio M.G., et al. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat. Cell Biol. 2000, 2:76-83.
33. Porta-de-la-Riva M., Stanisavljevic J., Curto J., Franci C., Diaz V.M., Garcia de Herreros A., et al. TFCP2c/LSF/LBP-1c is required for Snail1-induced fibronectin gene expression. Biochem. J. 2011, 435:563-568.
34. Peinado H., Ballestar E., Esteller M., Cano A. Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex. Mol. Cell. Biol. 2004, 24:306-319.
35. Herranz N., Pasini D., Diaz V.M., Franci C., Gutierrez A., Dave N., et al. Polycomb complex 2 is required for E-cadherin repression by the Snail1 transcription factor. Mol. Cell. Biol. 2008, 28:4772-4781.
36. Hou Z., Peng H., Ayyanathan K., Yan K.P., Langer E.M., Longmore G.D., et al. The LIM protein AJUBA recruits protein arginine methyltransferase 5 to mediate SNAIL-dependent transcriptional repression. Mol. Cell. Biol. 2008, 28:3198-3207.
37. Lin Y., Wu Y., Li J., Dong C., Ye X., Chi Y.I., et al. The SNAG domain of Snail1 functions as a molecular hook for recruiting lysine-specific demethylase 1. EMBO J. 2010, 29:1803-1816.
38. Tang M., Shen H., Jin Y., Lin T., Cai Q., Pinard M.A., et al. The malignant brain tumor (MBT) domain protein SFMBT1 is an integral histone reader subunit of the LSD1 demethylase complex for chromatin association and epithelial-to-mesenchymal transition. J. Biol. Chem. 2013, 288:27680-27691.
39. Ko H., Kim H.S., Kim N.H., Lee S.H., Kim K.H., Hong S.H., et al. Nuclear localization signals of the E-cadherin transcriptional repressor Snail. Cell Tissues Organs 2007, 185:66-72.
40. 2 zinc finger transcription factors. J. Cell Sci. 2009, 122:1452-1460.
41. Vandewalle C., Comijn J., De Craene B., Vermassen P., Bruyneel E., Andersen H., et al. SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions. Nucleic Acids Res. 2005, 33:6566-6578.
42. Drake J.M., Strohbehn G., Bair T.B., Moreland J.G., Henry M.D. ZEB1 enhances transendothelial migration and represses the epithelial phenotype of prostate cancer cells. Mol. Biol. Cell 2009, 20:2207-2217.
43. Sanchez-Tillo E., Liu Y., de Barrios O., Siles L., Fanlo L., Cuatrecasas M., et al. EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness. Cell Mol. Life Sci. 2012, 69:3429-3456.
44. Postigo A.A., Dean D.C. ZEB represses transcription through interaction with the corepressor CtBP. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:6683-6688.
45. Sanchez-Tillo E., Lazaro A., Torrent R., Cuatrecasas M., Vaquero E.C., Castells A., et al. ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatin-remodeling protein BRG1. Oncogene 2010, 29:3490-3500.
46. Teng Y., Li X. The roles of HLH transcription factors in epithelial mesenchymal transition and multiple molecular mechanisms. Clin. Exp. Metastasis 2014, 31:367-377.
47. Fu J., Qin L., He T., Qin J., Hong J., Wong J., et al. The TWIST/Mi2/NuRD protein complex and its essential role in cancer metastasis. Cell Res. 2011, 21:275-289.
48. Yang F., Sun L., Li Q., Han X., Lei L., Zhang H., et al. SET8 promotes epithelial-mesenchymal transition and confers TWIST dual transcriptional activities. EMBO J. 2012, 31:110-123.
49. Lee K., Gjorevski N., Boghaert E., Radisky D.C., Nelson C.M. Snail1, Snail2 and E47 promote mammary epithelial branching morphogenesis. EMBO J. 2011, 30:2662-2674.
50. Sobrado V.R., Moreno-Bueno G., Cubillo E., Holt L.J., Nieto M.A., Portillo F., et al. The class I bHLH factors E2-2A and E2-2B regulate EMT. J. Cell Sci. 2009, 122:1014-1024.
51. Cano A., Portillo F. An emerging role for class I bHLH E2-proteins in EMT regulation and tumor progression. Cell Adhes. Migr. 2010, 4:56-60.
52. Limame R., Op de Beeck K., Lardon F., De Wever O., Pauwels P. Kruppel-like factors in cancer progression: three fingers on the steering wheel. Oncotarget 2014, 5:29-48.
53. Wang X., Zheng M., Liu G., Xia W., McKeown-Longo P.J., Hung M.C., et al. Kruppel-like factor 8 induces epithelial to mesenchymal transition and epithelial cell invasion. Cancer Res. 2007, 67:7184-7193.
54. Sanchez-Tillo E., de Barrios O., Siles L., Cuatrecasas M., Castells A., Postigo A. beta-catenin/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:19204-19209.
55. Dave N., Guaita-Esteruelas S., Gutarra S., Frias A., Beltran M., Peiro S., et al. Functional cooperation between Snail1 and twist in the regulation of ZEB1 expression during epithelial to mesenchymal transition. J. Biol. Chem. 2011, 286:12024-12032.
56. Yang M.H., Wu M.Z., Chiou S.H., Chen P.M., Chang S.Y., Liu C.J., et al. Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nat. Cell Biol. 2008, 10:295-305.
57. Thiery J.P., Sleeman J.P. Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Biol. 2006, 7:131-142.
58. Grotegut S., von Schweinitz D., Christofori G., Lehembre F. Hepatocyte growth factor induces cell scattering through MAPK/Egr-1-mediated upregulation of Snail. EMBO J. 2006, 25:3534-3545.
59. Fuxe J., Vincent T., Garcia de Herreros A. Transcriptional crosstalk between TGF-beta and stem cell pathways in tumor cell invasion: role of EMT promoting Smad complexes. Cell Cycle 2010, 9:2363-2374.
60. Giannoni E., Parri M., Chiarugi P. EMT and oxidative stress: a bidirectional interplay affecting tumor malignancy. Antioxid. Redox Signal. 2012, 16:1248-1263.
61. Chen J., Imanaka N., Griffin J.D. Hypoxia potentiates Notch signaling in breast cancer leading to decreased E-cadherin expression and increased cell migration and invasion. Br. J. Cancer 2010, 102:351-360.
62. Kim C.H., Jeon H.M., Lee S.Y., Ju M.K., Moon J.Y., Park H.G., et al. Implication of snail in metabolic stress-induced necrosis. PLoS ONE 2011, 6:e18000.
63. Dong R., Lu J.G., Wang Q., He X.L., Chu Y.K., Ma Q.J. Stabilization of Snail by HuR in the process of hydrogen peroxide induced cell migration. Biochem. Biophys. Res. Commun. 2007, 356:318-321.
64. Radisky D.C., Levy D.D., Littlepage L.E., Liu H., Nelson C.M., Fata J.E., et al. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 2005, 436:123-127.
65. Barnett P., Arnold R.S., Mezencev R., Chung L.W., Zayzafoon M., Odero-Marah V. Snail-mediated regulation of reactive oxygen species in ARCaP human prostate cancer cells. Biochem. Biophys. Res. Commun. 2011, 404:34-39.
66. Kajita M., McClinic K.N., Wade P.A. Aberrant expression of the transcription factors snail and slug alters the response to genotoxic stress. Mol. Cell. Biol. 2004, 24:7559-7566.
67. Rosano L., Cianfrocca R., Spinella F., Di Castro V., Nicotra M.R., Lucidi A., et al. Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells. Clin. Cancer Res. 2011, 17:2350-2360.
68. Hoshino H., Miyoshi N., Nagai K., Tomimaru Y., Nagano H., Sekimoto M., et al. Epithelial-mesenchymal transition with expression of SNAI1-induced chemoresistance in colorectal cancer. Biochem. Biophys. Res. Commun. 2009, 390:1061-1065.
69. Zhang W., Feng M., Zheng G., Chen Y., Wang X., Pen B., et al. Chemoresistance to 5-fluorouracil induces epithelial-mesenchymal transition via up-regulation of Snail in MCF7 human breast cancer cells. Biochem. Biophys. Res. Commun. 2012, 417:679-685.
70. Haslehurst A.M., Koti M., Dharsee M., Nuin P., Evans K., Geraci J., et al. EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer. BMC Cancer 2012, 12:91.
71. Izumiya M., Kabashima A., Higuchi H., Igarashi T., Sakai G., Iizuka H., et al. Chemoresistance is associated with cancer stem cell-like properties and epithelial-to-mesenchymal transition in pancreatic cancer cells. Anticancer Res. 2012, 32:3847-3853.
72. Zhou Y.C., Liu J.Y., Li J., Zhang J., Xu Y.Q., Zhang H.W., et al. Ionizing radiation promotes migration and invasion of cancer cells through transforming growth factor-beta-mediated epithelial-mesenchymal transition. Int. J. Radiat. Oncol. Biol. Phys. 2011, 81:1530-1537.
73. Tran H.D., Luitel K., Kim M., Zhang K., Longmore G.D., Tran D.D. Transient SNAIL1 expression is necessary for metastatic competence in breast cancer. Cancer Res. 2014, 74:6330-6340.
74. Diaz V.M., Vinas-Castells R., Garcia de Herreros A. Regulation of the protein stability of EMT transcription factors. Cell Adhes. Migr. 2014, 8:418-428.
75. Zhou B.P., Deng J., Xia W., Xu J., Li Y.M., Gunduz M., et al. Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat. Cell Biol. 2004, 6:931-940.
76. Wu Z.Q., Li X.Y., Hu C.Y., Ford M., Kleer C.G., Weiss S.J. Canonical Wnt signaling regulates Slug activity and links epithelial-mesenchymal transition with epigenetic Breast Cancer 1, Early Onset (BRCA1) repression. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:16654-16659.
77. Su Y.W., Xie T.X., Sano D., Myers J.N. IL-stabilizes Twist and enhances tumor cell motility in head and neck cancer cells through activation of casein kinase 2. PLoS ONE 2011, 6:e19412.
78. Nagarajan D., Melo T., Deng Z., Almeida C., Zhao W. ERK/GSK3beta/Snail signaling mediates radiation-induced alveolar epithelial-to-mesenchymal transition. Free Radical Biol. Med. 2012, 52:983-992.
79. Sun M., Guo X., Qian X., Wang H., Yang C., Brinkman K.L., et al. Activation of the ATM-Snail pathway promotes breast cancer metastasis. J. Mol. Cell. Biol. 2012, 4:304-315.
80. Vinas-Castells R., Frias A., Robles-Lanuza E., Zhang K., Longmore G.D., Garcia de Herreros A., et al. Nuclear ubiquitination by FBXL5 modulates Snail1 DNA binding and stability. Nucleic Acids Res. 2014, 42:1079-1094.
81. Yaron A., Hatzubai A., Davis M., Lavon I., Amit S., Manning A.M., et al. Identification of the receptor component of the IkappaBalpha-ubiquitin ligase. Nature 1998, 396:590-594.
82. Hart M., Concordet J.P., Lassot I., Albert I., del los Santos R., Durand H., et al. The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell. Curr. Biol. 1999, 9:207-210.
83. Skaar J.R., D'Angiolella V., Pagan J.K., Pagano M. SnapShot: F box proteins II. Cell 2009, 137:1358, e1.
84. Guardavaccaro D., Kudo Y., Boulaire J., Barchi M., Busino L., Donzelli M., et al. Control of meiotic and mitotic progression by the F box protein beta-Trcp1 in vivo. Dev. Cell 2003, 4:799-812.
85. Kanarek N., Horwitz E., Mayan I., Leshets M., Cojocaru G., Davis M., et al. Spermatogenesis rescue in a mouse deficient for the ubiquitin ligase SCF β -TrCP by single substrate depletion. Genes Dev. 2010, 24:470-477.
86. Wu G., Xu G., Schulman B.A., Jeffrey P.D., Harper J.W., Pavletich N.P. Structure of a beta-TrCP1-Skp1-beta-catenin complex: destruction motif binding and lysine specificity of the SCF(beta-TrCP1) ubiquitin ligase. Mol. Cell 2003, 11:1445-1456.
87. Yook J.I., Li X.Y., Ota I., Fearon E.R., Weiss S.J. Wnt-dependent regulation of the E-cadherin repressor snail. J. Biol. Chem. 2005, 280:11740-11748.
88. Dominguez D., Montserrat-Sentis B., Virgos-Soler A., Guaita S., Grueso J., Porta M., et al. Phosphorylation regulates the subcellular location and activity of the snail transcriptional repressor. Mol. Cell. Biol. 2003, 23:5078-5089.
89. Xu Y., Lee S.H., Kim H.S., Kim N.H., Piao S., Park S.H., et al. Role of CK1 in GSK3beta-mediated phosphorylation and degradation of snail. Oncogene 2010, 29:3124-3133.
90. Deshiere A., Duchemin-Pelletier E., Spreux E., Ciais D., Combes F., Vandenbrouck Y., et al. Unbalanced expression of CK2 kinase subunits is sufficient to drive epithelial-to-mesenchymal transition by Snail1 induction. Oncogene 2013, 32:1373-1383.
91. Mimoto R., Taira N., Takahashi H., Yamaguchi T., Okabe M., Uchida K., et al. DYRK2 controls the epithelial-mesenchymal transition in breast cancer by degrading Snail. Cancer Lett. 2013, 339:214-225.
92. Wu Y., Evers B.M., Zhou B.P. Small C-terminal domain phosphatase enhances snail activity through dephosphorylation. J. Biol. Chem. 2009, 284:640-648.
93. Yook J.I., Li X.Y., Ota I., Hu C., Kim H.S., Kim N.H., et al. A Wnt-Axin2-GSK3beta cascade regulates Snail1 activity in breast cancer cells. Nat. Cell Biol. 2006, 8:1398-1406.
94. Park S.Y., Kim H.S., Kim N.H., Ji S., Cha S.Y., Kang J.G., et al. Snail1 is stabilized by O-GlcNAc modification in hyperglycaemic condition. EMBO J. 2010, 29:3787-3796.
95. Zhang K., Rodriguez-Aznar E., Yabuta N., Owen R.J., Mingot J.M., Nojima H., et al. Lats2 kinase potentiates Snail1 activity by promoting nuclear retention upon phosphorylation. EMBO J. 2012, 31:29-43.
96. Yang Z., Rayala S., Nguyen D., Vadlamudi R.K., Chen S., Kumar R. Pak1 phosphorylation of snail, a master regulator of epithelial-to-mesenchyme transition, modulates snail's subcellular localization and functions. Cancer Res. 2005, 65:3179-3184.
97. Zhang K., Corsa C.A., Ponik S.M., Prior J.L., Piwnica-Worms D., Eliceiri K.W., et al. The collagen receptor discoidin domain receptor 2 stabilizes SNAIL1 to facilitate breast cancer metastasis. Nat. Cell Biol. 2013, 15:677-687.
98. Wettstein G., Bellaye P.S., Kolb M., Hammann A., Crestani B., Soler P., et al. Inhibition of HSP27 blocks fibrosis development and E.M.T. features by promoting Snail degradation. FASEB J. 2013, 27:1549-1560.
99. Wu Y., Deng J., Rychahou P.G., Qiu S., Evers B.M., Zhou B.P. Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion. Cancer Cell 2009, 15:416-428.
100. Hong J., Zhou J., Fu J., He T., Qin J., Wang L., et al. Phosphorylation of serine 68 of Twist1 by MAPKs stabilizes Twist1 protein and promotes breast cancer cell invasiveness. Cancer Res. 2011, 71:3980-3990.
101. Kim J.Y., Kim Y.M., Yang C.H., Cho S.K., Lee J.W., Cho M. Functional regulation of Slug/Snail2 is dependent on GSK-3beta-mediated phosphorylation. FEBS J. 2012, 279:2929-2939.
102. Molina-Ortiz P., Villarejo A., MacPherson M., Santos V., Montes A., Souchelnytskyi S., et al. Characterization of the SNAG and SLUG domains of Snail2 in the repression of E-cadherin and EMT induction: modulation by serine 4 phosphorylation. PLoS ONE 2012, 7:e36132.
103. Zhong J., Ogura K., Wang Z., Inuzuka H. Degradation of the transcription factor Twist, an oncoprotein that promotes cancer metastasis. Discovery Med. 2013, 15:7-15.
104. Wang S.P., Wang W.L., Chang Y.L., Wu C.T., Chao Y.C., Kao S.H., et al. p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug. Nat. Cell Biol. 2009, 11:694-704.
105. Lim S.O., Kim H., Jung G. p53 inhibits tumor cell invasion via the degradation of snail protein in hepatocellular carcinoma. FEBS Lett. 2010, 584:2231-2236.
106. Inuzuka H., Tseng A., Gao D., Zhai B., Zhang Q., Shaik S., et al. Phosphorylation by casein kinase I promotes the turnover of the Mdm2 oncoprotein via the SCF(beta-TRCP) ubiquitin ligase. Cancer Cell 2010, 18:147-159.
107. Welcker M., Clurman B.E. FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat. Rev. Cancer 2008, 8:83-93.
108. Cheng Y., Li G. Role of the ubiquitin ligase Fbw7 in cancer progression. Cancer Metastasis Rev. 2012, 31:75-87.
109. Davis R.J., Welcker M., Clurman B.E. Tumor suppression by the Fbw7 ubiquitin ligase: mechanisms and opportunities. Cancer Cell 2014, 26:455-464.
110. Yada M., Hatakeyama S., Kamura T., Nishiyama M., Tsunematsu R., Imaki H., et al. Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7. EMBO J. 2004, 23:2116-2125.
111. Welcker M., Orian A., Grim J.E., Eisenman R.N., Clurman B.E. A nucleolar isoform of the Fbw7 ubiquitin ligase regulates c-Myc and cell size. Curr. Biol. 2004, 14:1852-1857.
112. Welcker M., Orian A., Jin J., Grim J.E., Harper J.W., Eisenman R.N., et al. The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:9085-9090.
113. Tetzlaff M.T., Yu W., Li M., Zhang P., Finegold M., Mahon K., et al. Defective cardiovascular development and elevated cyclin E and Notch proteins in mice lacking the Fbw7 F-box protein. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:3338-3345.
114. Gao J., Azmi A.S., Aboukameel A., Kauffman M., Shacham S., Abou-Samra A.B., et al. Nuclear retention of Fbw7 by specific inhibitors of nuclear export leads to Notch1 degradation in pancreatic cancer. Oncotarget 2014, 5:3444-3454.
115. Timmerman L.A., Grego-Bessa J., Raya A., Bertran E., Perez-Pomares J.M., Diez J., et al. Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. Genes Dev. 2004, 18:99-115.
116. Cowling V.H., Cole M.D. E-cadherin repression contributes to c-Myc-induced epithelial cell transformation. Oncogene 2007, 26:3582-3586.
117. Minella A.C., Welcker M., Clurman B.E. Ras activity regulates cyclin E degradation by the Fbw7 pathway. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:9649-9654.
118. Akhoondi S., Sun D., von der Lehr N., Apostolidou S., Klotz K., Maljukova A., et al. FBXW7/hCDC4 is a general tumor suppressor in human cancer. Cancer Res. 2007, 67:9006-9012.
119. O'Neil J., Grim J., Strack P., Rao S., Tibbitts D., Winter C., et al. FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors. J. Exp. Med. 2007, 204:1813-1824.
120. Thompson B.J., Buonamici S., Sulis M.L., Palomero T., Vilimas T., Basso G., et al. The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia. J. Exp. Med. 2007, 204:1825-1835.
121. King B., Trimarchi T., Reavie L., Xu L., Mullenders J., Ntziachristos P., et al. The ubiquitin ligase FBXW7 modulates leukemia-initiating cell activity by regulating MYC stability. Cell 2013, 153:1552-1566.
122. Schulein-Volk C., Wolf E., Zhu J., Xu W., Taranets L., Hellmann A., et al. Dual regulation of Fbw7 function and oncogenic transformation by Usp28. Cell Rep. 2014, 9:1099-1109.
123. Min S.H., Lau A.W., Lee T.H., Inuzuka H., Wei S., Huang P., et al. Negative regulation of the stability and tumor suppressor function of Fbw7 by the Pin1 prolyl isomerase. Mol. Cell 2012, 46:771-783.
124. Mao J.H., Kim I.J., Wu D., Climent J., Kang H.C., DelRosario R., et al. FBXW7 targets mTOR for degradation and cooperates with PTEN in tumor suppression. Science 2008, 321:1499-1502.
125. Kitagawa K., Hiramatsu Y., Uchida C., Isobe T., Hattori T., Oda T., et al. Fbw7 promotes ubiquitin-dependent degradation of c-Myb: involvement of GSK3-mediated phosphorylation of Thr-572 in mouse c-Myb. Oncogene 2009, 28:2393-2405.
126. Wertz I.E., Kusam S., Lam C., Okamoto T., Sandoval W., Anderson D.J., et al. Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7. Nature 2011, 471:110-114.
127. Arabi A., Ullah K., Branca R.M., Johansson J., Bandarra D., Haneklaus M., et al. Proteomic screen reveals Fbw7 as a modulator of the NF-kappaB pathway. Nat. Commun. 2012, 3:976.
128. Wang Y., Liu Y., Lu J., Zhang P., Wang Y., Xu Y., et al. Rapamycin inhibits FBXW7 loss-induced epithelial-mesenchymal transition and cancer stem cell-like characteristics in colorectal cancer cells. Biochem. Biophys. Res. Commun. 2013, 434:352-356.
129. Wang Z., Liu Y., Zhang P., Zhang W., Wang W., Curr K., et al. FAM83D promotes cell proliferation and motility by downregulating tumor suppressor gene FBXW7. Oncotarget 2013, 4:2476-2486.
130. Yang H., Lu X., Liu Z., Chen L., Xu Y., Wang Y., et al. FBXW7 suppresses epithelial-mesenchymal transition, stemness and metastatic potential of cholangiocarcinoma cells. Oncotarget 2015, 6:6310-6325.
131. Vernon A.E., LaBonne C. Slug stability is dynamically regulated during neural crest development by the F-box protein Ppa. Development 2006, 133:3359-3370.
132. Lander R., Nordin K., LaBonne C. The F-box protein Ppa is a common regulator of core EMT factors Twist, Snail, Slug, and Sip1. J. Cell Biol. 2011, 194:17-25.
133. Das T., Purkayastha-Mukherjee C., D'Angelo J., Weir M. A conserved F-box gene with unusual transcript localization. Dev Genes Evol. 2002, 212:134-140.
134. Vinas-Castells R., Beltran M., Valls G., Gomez I., Garcia J.M., Montserrat-Sentis B., et al. The hypoxia-controlled FBXL14 ubiquitin ligase targets SNAIL1 for proteasome degradation. J. Biol. Chem. 2010, 285:3794-3805.
135. Yang W.H., Su Y.H., Hsu W.H., Wang C.C., Arbiser J.L., Yang M.H. Imipramine blue halts head and neck cancer invasion through promoting F-box and leucine-rich repeat protein 14-mediated Twist1 degradation. Oncogene 2015, 10.1038/onc.2015.291.
136. Salahudeen A.A., Thompson J.W., Ruiz J.C., Ma H.W., Kinch L.N., Li Q., et al. An E3 ligase possessing an iron-responsive hemerythrin domain is a regulator of iron homeostasis. Science 2009, 326:722-726.
137. Vashisht A.A., Zumbrennen K.B., Huang X., Powers D.N., Durazo A., Sun D., et al. Control of iron homeostasis by an iron-regulated ubiquitin ligase. Science 2009, 326:718-721.
138. Shu C., Sung M.W., Stewart M.D., Igumenova T.I., Tan X., Li P. The structural basis of iron sensing by the human F-box protein FBXL5. ChemBioChem 2012, 13:788-791.
139. Thompson J.W., Salahudeen A.A., Chollangi S., Ruiz J.C., Brautigam C.A., Makris T.M., et al. Structural and molecular characterization of iron-sensing hemerythrin-like domain within F-box and leucine-rich repeat protein 5 (FBXL5). J. Biol. Chem. 2012, 287:7357-7365.
140. Moroishi T., Nishiyama M., Takeda Y., Iwai K., Nakayama K.I. The FBXL5-IRP2 axis is integral to control of iron metabolism in vivo. Cell Metab. 2011, 14:339-351.
141. Sefton M., Sanchez S., Nieto M.A. Conserved and divergent roles for members of the Snail family of transcription factors in the chick and mouse embryo. Development 1998, 125:3111-3121.
142. Hsu D.S., Wang H.J., Tai S.K., Chou C.H., Hsieh C.H., Chiu P.H., et al. Acetylation of snail modulates the cytokinome of cancer cells to enhance the recruitment of macrophages. Cancer Cell 2014, 26:534-548.
143. Muqbil I., Wu J., Aboukameel A., Mohammad R.M., Azmi A.S. Snail nuclear transport: the gateways regulating epithelial-to-mesenchymal transition?. Semin Cancer Biol. 2014, 27:39-45.
144. Rockel T.D., Stuhlmann D., von Mikecz A. Proteasomes degrade proteins in focal subdomains of the human cell nucleus. J. Cell Sci. 2005, 118:5231-5242.
145. Chen Z.W., Liu B., Tang N.W., Xu Y.H., Ye X.Y., Li Z.M., et al. FBXL5-mediated degradation of single-stranded DNA-binding protein hSSB1 controls DNA damage response. Nucleic Acids Res. 2014, 42:1156-1159.
146. Richard D.J., Bolderson E., Cubeddu L., Wadsworth R.I., Savage K., Sharma G.G., et al. Single-stranded DNA-binding protein hSSB1 is critical for genomic stability. Nature 2008, 453:677-681.
147. Wu W., Ding H., Cao J., Zhang W. FBXL5 inhibits metastasis of gastric cancer through suppressing Snail1. Cell Physiol. Biochem. 2015, 35:1764-1772.
148. Cen G., Ding H.H., Liu B., Wu W.D. FBXL5 targets cortactin for ubiquitination-mediated destruction to regulate gastric cancer cell migration. Tumour Biol. 2014, 35:8633-8638.
149. Zheng H., Shen M., Zha Y.L., Li W., Wei Y., Blanco M.A., et al. PKD1 phosphorylation-dependent degradation of SNAIL by SCF-FBXO11 regulates epithelial-mesenchymal transition and metastasis. Cancer Cell 2014, 26:358-373.
150. Jin Y., Shenoy A.K., Doernberg S., Chen H., Luo H., Shen H., et al. FBXO11 promotes ubiquitination of the Snail family of transcription factors in cancer progression and epidermal development. Cancer Lett. 2015, 362:70-82.
151. Duan S., Cermak L., Pagan J.K., Rossi M., Martinengo C., di Celle P.F., et al. FBXO11 targets BCL6 for degradation and is inactivated in diffuse large B-cell lymphomas. Nature 2012, 481:90-93.
152. Abida W.M., Nikolaev A., Zhao W., Zhang W., Gu W. FBXO11 promotes the Neddylation of p53 and inhibits its transcriptional activity. J. Biol. Chem. 2007, 282:1797-1804.
153. Abbas T., Mueller A.C., Shibata E., Keaton M., Rossi M., Dutta A. CRL1-FBXO11 promotes Cdt2 ubiquitylation and degradation and regulates Pr-Set7/Set8-mediated cellular migration. Mol. Cell 2013, 49:1147-1158.
154. Rossi M., Duan S., Jeong Y.T., Horn M., Saraf A., Florens L., et al. Regulation of the CRL4(Cdt2) ubiquitin ligase and cell-cycle exit by the SCF(Fbxo11) ubiquitin ligase. Mol. Cell 2013, 49:1159-1166.
155. Du C., Zhang C., Hassan S., Biswas M.H., Balaji K.C. Protein kinase D1 suppresses epithelial-to-mesenchymal transition through phosphorylation of snail. Cancer Res. 2010, 70:7810-7819.
156. Bastea L.I., Doppler H., Balogun B., Storz P. Protein kinase D1 maintains the epithelial phenotype by inducing a DNA-bound, inactive SNAI1 transcriptional repressor complex. PLoS ONE 2012, 7:e30459.
157. Eiseler T., Kohler C., Nimmagadda S.C., Jamali A., Funk N., Joodi G., et al. Protein kinase D1 mediates anchorage-dependent and -independent growth of tumor cells via the zinc finger transcription factor Snail1. J. Biol. Chem. 2012, 287:3236-3280.
158. Yoshida K. Characterization of estrogen-induced F-box protein FBXO45. Oncol. Rep. 2005, 14:531-535.
159. Saiga T., Fukuda T., Matsumoto M., Tada H., Okano H.J., Okano H., et al. Fbxo45 forms a novel ubiquitin ligase complex and is required for neuronal development. Mol. Cell. Biol. 2009, 29:3529-3543.
160. Han S., Kim S., Bahl S., Li L., Burande C.F., Smith N., et al. The E3 ubiquitin ligase protein associated with Myc (Pam) regulates mammalian/mechanistic target of rapamycin complex 1 (mTORC1) signaling in vivo through N- and C-terminal domains. J. Biol. Chem. 2012, 287:3006-3072.
161. Chen X., Sahasrabuddhe A.A., Szankasi P., Chung F., Basrur V., Rangnekar V.M., et al. Fbxo45-mediated degradation of the tumor-suppressor Par-regulates cancer cell survival. Cell Death Differ. 2014, 21:1535-1545.
162. Xu M., Zhu C., Zhao X., Chen C., Zhang H., Yuan H., et al. Atypical ubiquitin E3 ligase complex Skp1-Pam-Fbxo45 controls the core epithelial-to-mesenchymal transition-inducing transcription factors. Oncotarget 2015, 6:979-994.
163. Dong S., Zhao J., Wei J., Bowser R.K., Khoo A., Liu Z., et al. F-box protein complex FBXL19 regulates TGFbeta1-induced E-cadherin down-regulation by mediating Rac3 ubiquitination and degradation. Mol. Cancer 2014, 13:76.
164. Wang Y., Wen M., Kwon Y., Xu Y., Liu Y., Zhang P., et al. CUL4A induces epithelial-mesenchymal transition and promotes cancer metastasis by regulating ZEB1 expression. Cancer Res. 2014, 74:520-531.
165. Popov N., Wanzel M., Madiredjo M., Zhang D., Beijersbergen R., Bernards R., et al. The ubiquitin-specific protease USP28 is required for MYC stability. Nat. Cell Biol. 2007, 9:765-774.
166. Salat D., Winkler A., Urlaub H., Gessler M. Hey bHLH proteins interact with a FBXO45 containing SCF ubiquitin ligase complex and induce its translocation into the nucleus. PLoS ONE 2015, 10:e0130288.